Abstract:Non-healing lesions in diabetic foot ulcers are a significant effect of poor angiogenesis. Epigenetic regulators, mainly lncRNA and miRNA, are recognized for their important roles in disease progression. We deciphered the regulation of lncRNA NEAT1 through the miR-146a-5p/mafG axis in the progression of DFU. A lowered expression of lncRNA NEAT1 was associated with dysregulated angiogenesis through the reduced expression of mafG, SDF-1α, and VEGF in chronic ulcer subjects compared to acute DFU. This was validated by silencing NEAT1 by SiRNA in the endothelial cells which resulted in the transcriptional repression of target genes. Our in silico analysis identified miR-146a-5p as a potential target of lncRNA NEAT1. Further, silencing NEAT1 led to an increase in the levels of miR-146a-5p in chronic DFU subjects. This research presents the role of the lncRNA NEAT1/miR-146a-5p/mafG axis in enhancing angiogenesis in DFU.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the problem of impaired angiogenesis in diabetic foot ulcers (DFU). Specifically, the study focused on how the interaction between long - non - coding RNA NEAT1 and miR - 146a - 5p affects the expression of angiogenesis - related genes, thereby restoring the normal angiogenesis process in DFU. The study found that lncRNA NEAT1 targets mafG by regulating miR - 146a - 5p, which in turn affects the expression of angiogenesis factors such as SDF - 1α and VEGF. These findings are helpful for understanding the molecular mechanism of angiogenesis disorders in DFU and may provide a theoretical basis for the development of new treatment strategies. ### Key Point Summary: 1. **Background Problem**: Diabetic foot ulcer (DFU) is a common complication, mainly characterized by poor wound healing, and one of the important reasons is impaired angiogenesis. 2. **Research Objective**: To explore the interaction between lncRNA NEAT1 and miR - 146a - 5p and its impact on angiogenesis, especially to restore normal angiogenesis in DFU by targeting mafG. 3. **Main Findings**: - The expression of lncRNA NEAT1 in patients with chronic DFU is significantly decreased. - Inhibiting the expression of lncRNA NEAT1 will lead to a decrease in the expression of angiogenesis - related genes (such as mafG, SDF - 1α and VEGF). - miR - 146a - 5p was identified as a potential target of lncRNA NEAT1, and its expression was significantly increased in patients with chronic DFU. - There is a significant negative correlation between miR - 146a - 5p and lncRNA NEAT1, and also a negative correlation with the expression of angiogenesis - related genes. ### Formula and Symbol Explanation: - **miR - 146a - 5p**: A microRNA, involved in the regulation of gene expression. - **mafG**: A transcription factor, related to glucose metabolism, antioxidant pathways and bile homeostasis. - **SDF - 1α**: Stromal cell - derived factor 1α, which promotes endothelial cell migration and retention, thereby promoting neovascularization. - **VEGF**: Vascular endothelial growth factor, which promotes vascular permeability and the proliferation, migration and survival of endothelial cells. ### Conclusion: By studying the interaction between lncRNA NEAT1 and miR - 146a - 5p and their regulation of mafG expression, the paper reveals the molecular mechanism of impaired angiogenesis in DFU. This finding not only deepens the understanding of the pathophysiology of DFU, but also provides potential targets for the development of new treatment strategies.

LncRNA NEAT1/miR-146a-5p Axis Restores Normal Angiogenesis in Diabetic Foot Ulcers by Targeting mafG

Angio-microRNAs in diabetic foot ulcer-: Mechanistic insights and clinical perspectives

LncRNA DLEU1 promotes angiogenesis in diabetic foot ulcer wound healing by regulating miR-96-5p

Expression of miR-217 and HIF-1α/VEGF pathway in patients with diabetic foot ulcer and its effect on angiogenesis of diabetic foot ulcer rats

Long non-coding RNA NEAT1 inhibits high glucose-induced EMT and renal fibrogenesis in Human Embryonic Kidney 293 cells via regulating miR-204/SOX4 axis

LncRNA NEAT1 Accelerates the Proliferation, Oxidative Stress, Inflammation, and Fibrosis and Suppresses the Apoptosis Through the miR-423-5p/GLIPR2 Axis in Diabetic Nephropathy

MicroRNA-375 repression of Kruppel-like factor 5 improves angiogenesis in diabetic critical limb ischemia

Interplay Between FoxM1 and Dab2 Promotes Endothelial Cell Responses in Diabetic Wound Healing

Single-cell RNA-seq and bulk-seq identify RAB17 as a potential regulator of angiogenesis by human dermal microvascular endothelial cells in diabetic foot ulcers

Exosomes from mmu_circ_0001052-modified adipose-derived stem cells promote angiogenesis of DFU via miR-106a-5p and FGF4/p38MAPK pathway

LncRNA NEAT1/microRNA-124 regulates cell viability, inflammation and fibrosis in high-glucose-treated mesangial cells

Lncrna-Miat Regulates Microvascular Dysfunction by Functioning As a Competing Endogenous RNA.

Epigenetic regulation of Nrf2-Mediated angiogenesis in diabetic foot ulcer progression: Role of histone deacetylases

Abstract 147: Endothelial Regulation By Enhancer Associated Long Non-coding RNA

The Combination of Vascular Endothelial Growth Factor A (VEGF-A) and Fibroblast Growth Factor 1 (FGF1) Modified mRNA Improves Wound Healing in Diabetic Mice: An Ex Vivo and In Vivo Investigation

LncRNA GAS5 activates the HIF1A/VEGF pathway by binding to TAF15 to promote wound healing in diabetic foot ulcers

LncRNA NEAT1 Promotes Extracellular Matrix Accumulation and Epithelial-to-mesenchymal Transition by Targeting Mir-27B-3p and ZEB1 in Diabetic Nephropathy

MiR-195-5p and miR-205-5p in extracellular vesicles isolated from diabetic foot ulcer wound fluid decrease angiogenesis by inhibiting VEGFA expression

Exosomal lncRNA KLF3-AS1 derived from bone marrow mesenchymal stem cells stimulates angiogenesis to promote diabetic cutaneous wound healing

lncRNA NEAT1/miR‐495‐3p regulates angiogenesis in burn sepsis through the TGF‐β1 and SMAD signaling pathways